User:Mr. Ibrahem/Sacrosidase

Sacrosidase, sold under the brand name Sucraid, is a medication used to treat congenital sucrase-isomaltase deficiency (CSID). Use may also help support the diagnosis of the condition in question. It is taken by mouth each time a person eats.

Common side effects include abdominal pain, nausea, diarrhea, trouble sleeping, and headache. Other side effects may include allergic reactions. It replace the enzyme sucrase which assists in the breakdown of sugar (sucrose) into simpler forms.

Sacrosidase was approved for medical use in the United States in 1998. In the United States 118 doses costa about 8,700 USD as of 2021. In Europe it is an orphan medicine.